Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: Singapore Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20111
20132
20151
20162
20191
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
National Cancer Centre, Singapore2
Biogen1
Blueprint Medicines Corporation1
Coherus Oncology, Inc.1
H3 Biomedicine Inc.1
Lion TCR Pte. Ltd.1
Mina Alpha Limited1
National University Hospital, Singapore1
Sichuan Huiyang Life Science and Technology Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular12
Liver Neoplasms6
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Colonic Neoplasms1
Hepatitis B1
Kidney Neoplasms1
Liver Diseases1
Melanoma1
Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.